• LAST PRICE
    6.4800
  • TODAY'S CHANGE (%)
    Trending Down-0.1600 (-2.4096%)
  • Bid / Lots
    6.2500/ 1
  • Ask / Lots
    7.0000/ 28
  • Open / Previous Close
    6.7100 / 6.6400
  • Day Range
    Low 6.3600
    High 6.7100
  • 52 Week Range
    Low 3.8500
    High 7.6000
  • Volume
    371,464
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 6.64
TimeVolumeMGTX
09:32 ET93096.71
09:33 ET1246.54
09:35 ET14506.535
09:37 ET67236.6852
09:39 ET2006.6311
09:42 ET29566.6
09:44 ET2006.59
09:46 ET11396.59
09:48 ET6456.52
09:51 ET10476.5498
09:53 ET1526.5496
09:57 ET21346.59
10:04 ET1006.54
10:08 ET3006.53
10:09 ET51106.44
10:11 ET97996.39
10:13 ET56076.415
10:15 ET56006.4131
10:18 ET2006.44
10:20 ET3006.425
10:22 ET12506.42
10:24 ET1006.4
10:26 ET6506.4
10:27 ET2006.395
10:29 ET23006.365
10:31 ET1006.38
10:33 ET3006.41
10:38 ET5576.4
10:40 ET1006.38
10:42 ET1006.4
10:44 ET3006.4167
10:45 ET1006.4
10:47 ET1006.41
10:54 ET2006.415
10:56 ET5036.385622
10:58 ET1006.39
11:00 ET11006.42
11:02 ET21006.405
11:03 ET4006.42
11:05 ET8326.435
11:09 ET2006.44
11:12 ET2016.44
11:14 ET2006.44
11:16 ET38506.49
11:18 ET5976.500081
11:20 ET1006.486
11:21 ET7476.483
11:23 ET1006.5
11:25 ET10006.51
11:30 ET1186.495
11:32 ET2006.5
11:36 ET3936.49
11:41 ET2006.485
11:43 ET1006.49
11:45 ET3006.5
11:48 ET4006.51
11:50 ET2306.525
11:52 ET19006.54
11:54 ET55216.58
11:56 ET2006.57
11:59 ET2026.57
12:01 ET4006.56
12:03 ET2996.56
12:06 ET1006.56
12:10 ET7006.55
12:12 ET1006.56
12:14 ET12296.56
12:15 ET3006.56
12:19 ET4006.58
12:24 ET4346.5797
12:28 ET1256.56
12:30 ET1006.565
12:32 ET1006.56
12:33 ET94286.56
12:35 ET5006.5606
12:37 ET1006.56
12:42 ET1006.56
12:48 ET3676.56
12:50 ET3006.56
12:51 ET6006.555
12:55 ET6006.55
12:57 ET2006.56
01:00 ET82776.5
01:02 ET6006.485
01:04 ET2006.485
01:06 ET12506.48
01:08 ET20006.48
01:11 ET1006.48
01:13 ET1006.475
01:15 ET1006.47
01:18 ET5006.48
01:20 ET1006.48
01:22 ET1006.48
01:24 ET1006.48
01:26 ET1006.48
01:29 ET7506.49
01:31 ET4256.4978
01:33 ET11006.49
01:36 ET1006.49
01:38 ET5006.5
01:40 ET2006.49
01:44 ET1006.49
01:45 ET38846.52
01:47 ET13106.51
01:49 ET1006.51
01:51 ET61006.51
01:54 ET3586.51
01:56 ET26506.49
01:58 ET7006.48
02:02 ET5006.485
02:03 ET1006.485
02:05 ET15006.49
02:09 ET14036.505
02:12 ET54166.51
02:16 ET423006.5088
02:18 ET2006.51
02:20 ET18006.51
02:21 ET4006.5
02:25 ET1006.51
02:27 ET2006.51
02:32 ET12196.5
02:34 ET6006.52
02:36 ET28536.51
02:39 ET160766.56
02:41 ET9006.5646
02:43 ET1006.59
02:45 ET155716.545
03:15 ET6006.455
03:17 ET11606.44
03:19 ET1006.47
03:21 ET20006.455
03:24 ET1006.455
03:26 ET18006.44
03:28 ET2006.45
03:30 ET7006.44
03:32 ET5006.44
03:33 ET11076.47
03:37 ET1006.49
03:44 ET2006.5
03:46 ET3006.5
03:48 ET24676.4892
03:50 ET7496.48
03:51 ET2496.48
03:53 ET1006.47
03:55 ET14526.49
03:57 ET111776.505
04:00 ET386826.48
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMGTX
MeiraGTx Holdings PLC
512.5M
-4.3x
---
United StatesTSHA
Taysha Gene Therapies Inc
465.2M
-32.9x
---
United StatesVERV
Verve Therapeutics Inc
455.5M
-1.9x
---
United StatesKZR
Kezar Life Sciences Inc
548.7M
-0.6x
---
United StatesPRTC
PureTech Health PLC
528.0M
-7.6x
---
United StatesSSII
SS Innovations International Inc
478.1M
-21.5x
---
As of 2024-11-16

Company Information

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage gene therapy company. The Company is focused on three distinct areas of unmet medical need: ocular diseases, including inherited retinal diseases (IRDs), as well as large degenerative ocular diseases, severe forms of xerostomia and neurodegenerative diseases. Its product pipeline includes botaretigene sparoparvovec or bota-vec, for the treatment of X-linked retinitis pigmentosa related to mutations in the retinitis pigmentosa GTPase regulator gene or XLRP-RPGR; AAV-hAQP1 for the treatment of radiation-induced Grade 2/3 Xerostomia; AAV-hAQP1 for the treatment of Sjogren’s Syndrome; AAV-GAD for the treatment of Parkinson’s Disease; AAV-RPE65 for the treatment of RPE65-asociated retinal dystrophy; AAV-CNGB3 and AAV-CNGA3 for the treatment of achromatopsia; AAV-AIPL1 for the treatment of LCA4, and AAV-RDH12 for the treatment of RDH12 mutation-associated retinal dystrophy.

Contact Information

Headquarters
450 EAST 29TH STREET, 14TH FLOORNEW YORK, NY, United States 10016
Phone
646-860-7985
Fax
---

Executives

Independent Chairman of the Board
Keith Harris
President, Chief Executive Officer, Director
Alexandria Forbes
Chief Financial Officer, Chief Operating Officer
Richard Giroux
General Counsel, Secretary
Robert Wollin
Chief Development Officer
Stuart Naylor

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$512.5M
Revenue (TTM)
$8.1M
Shares Outstanding
77.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.24
EPS
$-1.49
Book Value
$2.17
P/E Ratio
-4.3x
Price/Sales (TTM)
63.1
Price/Cash Flow (TTM)
---
Operating Margin
-2,083.19%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.